We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.32B
AUM Growth
+$263M
Cap. Flow
+$81.3M
Cap. Flow %
1.53%
Top 10 Hldgs %
24.53%
Holding
923
New
177
Increased
263
Reduced
239
Closed
141

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$30.8M
2
WP
Worldpay, Inc.
WP
+$19.5M
3
UNP icon
Union Pacific
UNP
+$15.4M
4
DG icon
Dollar General
DG
+$13.1M
5
SBUX icon
Starbucks
SBUX
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.66%
2 Technology 16.19%
3 Consumer Discretionary 13.83%
4 Financials 12.22%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STJ
251
DELISTED
St Jude Medical
STJ
$1.26M 0.02%
15,840
+2,980
+23% +$241K
OMCL icon
252
Omnicell
OMCL
$1.86B
$1.24M 0.02%
32,395
+1,023
+3% +$38.1K
MRCC
253
DELISTED
Monroe Capital Corp
MRCC
$1.24M 0.02%
78,719
+24,999
+47% +$389K
WDAY icon
254
Workday
WDAY
$33.4B
$1.23M 0.02%
13,415
-1,885
-12% -$157K
GMED icon
255
Globus Medical
GMED
$10.4B
$1.23M 0.02%
+54,460
New +$1.28M
AXDX
256
DELISTED
Accelerate Diagnostics
AXDX
$1.22M 0.02%
4,461
+1,743
+64% +$386K
STMP
257
DELISTED
Stamps.com, Inc.
STMP
$1.2M 0.02%
12,646
+1,624
+15% +$141K
NFX
258
DELISTED
Newfield Exploration
NFX
$1.19M 0.02%
27,390
+145
+0.5% +$6.37K
CARB
259
DELISTED
Carbonite Inc
CARB
$1.19M 0.02%
77,224
+677
+0.9% +$8.59K
WWD icon
260
Woodward
WWD
$25B
$1.19M 0.02%
18,962
+465
+3% +$28K
SNN icon
261
Smith & Nephew
SNN
$12.9B
$1.18M 0.02%
36,117
-600
-2% -$20.1K
FNV icon
262
Franco-Nevada
FNV
$41.4B
$1.16M 0.02%
16,657
+2,152
+15% +$161K
HII icon
263
Huntington Ingalls Industries
HII
$11.3B
$1.16M 0.02%
7,575
+245
+3% +$40.6K
INGR icon
264
Ingredion
INGR
$6.38B
$1.15M 0.02%
8,665
-20
-0.2% -$2.67K
VFC icon
265
VF Corp
VFC
$6.68B
$1.13M 0.02%
21,390
-5,866
-22% -$339K
IWD icon
266
iShares Russell 1000 Value ETF
IWD
$82B
$1.11M 0.02%
10,553
+35
+0.3% +$3.69K
FIVE icon
267
Five Below
FIVE
$11.2B
$1.11M 0.02%
27,541
+13,624
+98% +$630K
NTUS
268
DELISTED
Natus Medical Inc
NTUS
$1.11M 0.02%
28,225
+262
+0.9% +$10.4K
LEG icon
269
Leggett & Platt
LEG
$1.52B
$1.09M 0.02%
24,025
ANSS
270
DELISTED
Ansys
ANSS
$1.09M 0.02%
11,784
+205
+2% +$19.1K
SRPT icon
271
Sarepta Therapeutics
SRPT
$1.66B
$1.08M 0.02%
+17,615
New +$533K
BRK.A icon
272
Berkshire Hathaway Class A
BRK.A
$1.07T
$1.08M 0.02%
5
DWTI
273
DELISTED
VelocityShares 3x Inverse Crude ETN linked to the S&P GSCI Crude Oil Index Excess Return
DWTI
$1.08M 0.02%
+16,076
New +$1.41M
AEK.CL
274
DELISTED
Aegon NV
AEK.CL
$1.08M 0.02%
40,366
-2,000
-5% -$54.2K
FWRD icon
275
Forward Air
FWRD
$482M
$1.06M 0.02%
24,482
+378
+2% +$17.2K

Similar funds

Geneva Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Geneva Advisors held 923 positions worth $5.32B, up 5.2% from $5.06B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q3 2016 filing shows 177 new, 263 increased, 239 reduced and 141 closed positions. Its largest new stake was A.O. Smith: 245,940 shares worth $12.1M. The largest sale was Bristol-Myers Squibb, an estimated $30.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Geneva Advisors's largest Q3 2016 buy was A.O. Smith: 245,940 shares worth $12.1M.
  • Geneva Advisors added most to Johnson Controls International in Q3 2016, an estimated $26.1M increase.
  • Geneva Advisors's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $30.8M.
  • Geneva Advisors fully exited McKesson in Q3 2016, selling an estimated $6.69M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.32B portfolio in Q3 2016.
  • Geneva Advisors opened 177 new positions and closed 141 in Q3 2016.
  • Geneva Advisors's portfolio value rose 5.2% quarter-over-quarter to $5.32B.

Based on Geneva Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.